A Mechanistic Test of Treatment Strategies to Foster Practice Quitting

Sponsor
Rush University Medical Center (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05513872
Collaborator
Medical University of South Carolina (Other)
780
1
4
54
14.4

Study Details

Study Description

Brief Summary

Tobacco use disorder is a chronic, relapsing health condition that necessitates a chronic care approach. However, traditional smoking cessation treatment programs allocate nearly all their resources only to those smokers who are willing to set a quit date. This is problematic because few smokers are ready to set a quit date at any given time, and a smoker's stated intention to quit can change rapidly.

One novel potential treatment strategy is to foster practice quitting (PQ), defined as attempting to not smoke for a few hours or days, without pressure or expectation to permanently quit. Although a growing body of evidence supports the role of practice quitting in fostering permanent quit attempts and cessation, there is a significant knowledge gap regarding which treatment strategies should be used to engage smokers in practice quitting. The proposed study will test the role of PQ counseling vs. Motivational Interviewing (MI) counseling, and NRT sampling (four-week supply of nicotine lozenges and patches) vs. none.

Condition or Disease Intervention/Treatment Phase
  • Drug: Nicotine Replacement Therapy (NRT) Sampling
  • Behavioral: Practice Quitting (PQ) Counseling
  • Behavioral: Motivational Interviewing (MI) Counseling
Phase 1/Phase 2

Detailed Description

Tobacco use disorder is a chronic, relapsing health condition that necessitates a chronic care approach. However, traditional smoking cessation treatment programs allocate nearly all their resources only to those smokers who are willing to set a quit date. This is problematic because few smokers are ready to set a quit date at any given time, and a smoker's stated intention to quit can change rapidly.

One novel potential treatment strategy is to foster practice quitting (PQ), defined as attempting to not smoke for a few hours or days, without pressure or expectation to permanently quit. Practice quitting represents a useful treatment exercise, as it offers a point of focus for behavior change coaching and goal-setting, with or without a planned quit date. The proposed study will test the role of PQ counseling vs. Motivational Interviewing (MI) counseling, and NRT sampling (four-week supply of nicotine lozenges and patches) vs. none. Specific aims are to:

Aim 1: Evaluate hypothesized mechanisms of action for PQ counseling and NRT sampling on incidence of quit attempts by 6 months among current smokers who are not planning to quit in the next 30 days (N=780). We will test the mediational effect of each variable on the relationship between PQ-focused treatment and incidence of quit attempts.

Aim 2: Test both the individual and combined roles of PQ counseling and NRT sampling on incidence of quit attempts by 6 months. We hypothesize that PQ counseling combined with NRT sampling will produce the highest rates of quit attempts through an additive relationship between these two treatment components.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
780 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
A Mechanistic Test of Treatment Strategies to Foster Practice Quitting
Anticipated Study Start Date :
Mar 1, 2023
Anticipated Primary Completion Date :
Aug 30, 2027
Anticipated Study Completion Date :
Aug 30, 2027

Arms and Interventions

Arm Intervention/Treatment
Experimental: Condition #1

NRT Sampling = On Behavioral Counseling = Practice Quitting

Drug: Nicotine Replacement Therapy (NRT) Sampling
Participants randomized to this condition will receive a 4-week nicotine replacement therapy (NRT) starter kit containing both nicotine lozenges and patches in their original packaging.

Behavioral: Practice Quitting (PQ) Counseling
Practice Quitting (PQ) counseling will consist of four weekly treatment sessions, with an initial 45-minute session followed by three 20-minute sessions. The goals of the counseling sessions are 1) to gradually expose patients to nicotine withdrawal symptoms through practice quitting, and 2) to reduce fear and avoidance of the physical sensations associated with nicotine withdrawal.

Experimental: Condition #2

NRT Sampling = Off Behavioral Counseling = Practice Quitting

Behavioral: Practice Quitting (PQ) Counseling
Practice Quitting (PQ) counseling will consist of four weekly treatment sessions, with an initial 45-minute session followed by three 20-minute sessions. The goals of the counseling sessions are 1) to gradually expose patients to nicotine withdrawal symptoms through practice quitting, and 2) to reduce fear and avoidance of the physical sensations associated with nicotine withdrawal.

Experimental: Condition #3

NRT sampling = On Behavioral counseling = Motivational Interviewing

Drug: Nicotine Replacement Therapy (NRT) Sampling
Participants randomized to this condition will receive a 4-week nicotine replacement therapy (NRT) starter kit containing both nicotine lozenges and patches in their original packaging.

Behavioral: Motivational Interviewing (MI) Counseling
Motivational Interviewing (MI) counseling will consist of four weekly treatment sessions, with an initial 45-minute session followed by three 20-minute sessions. Counseling content will incorporate MI-consistent principles, such as open questions, simple and complex reflections, and affirmations to facilitate participant statements in favor of behavior change. Discussion will focus on the motivational topics outlined in the USPHS guidelines for smokers not ready to quit: 1) relevance of smoking cessation or reduction to the individual, 2) risks of continued heavy smoking, 3) rewards of quitting and reduction, and 4) roadblocks to success, on a 5) repeated basis.

Experimental: Condition #4

NRT sampling = Off Behavioral counseling = Motivational Interviewing

Behavioral: Motivational Interviewing (MI) Counseling
Motivational Interviewing (MI) counseling will consist of four weekly treatment sessions, with an initial 45-minute session followed by three 20-minute sessions. Counseling content will incorporate MI-consistent principles, such as open questions, simple and complex reflections, and affirmations to facilitate participant statements in favor of behavior change. Discussion will focus on the motivational topics outlined in the USPHS guidelines for smokers not ready to quit: 1) relevance of smoking cessation or reduction to the individual, 2) risks of continued heavy smoking, 3) rewards of quitting and reduction, and 4) roadblocks to success, on a 5) repeated basis.

Outcome Measures

Primary Outcome Measures

  1. Any incidence of a quit attempt [At 6-month follow-up assessment]

    Intentional abstinence of ≥ 24 hours between the end of treatment and the 6-month follow-up assessment

Secondary Outcome Measures

  1. Abstinence status at 1-month follow-up [At 1-month follow-up assessment]

    Self-report of no smoking (not even a puff) within the previous 7 days, confirmed by an expired carbon monoxide (CO) reading of ≤ 6 parts per million (ppm).

  2. Abstinence status at 3-month follow-up [At 3-month follow-up assessment]

    Self-report of no smoking (not even a puff) within the previous 7 days, confirmed by an expired carbon monoxide (CO) reading of ≤ 6 parts per million (ppm).

  3. Abstinence status at 6-month follow-up [At 6-month follow-up assessment]

    Self-report of no smoking (not even a puff) within the previous 7 days, confirmed by an expired carbon monoxide (CO) reading of ≤ 6 parts per million (ppm).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
Eligible participants will be males and females who:
  1. are 18 years or older

  2. report current daily cigarette smoking (≥ 5 cigarettes per day)

  3. are not planning to quit in the next 30 days

  4. are motivated to quit or engage in a non-cessation goal (i.e., reduce smoking, learn more about treatment options, and/ or try out skills to change smoking) in the next 6 months

  5. are English speaking

  6. have access to a smartphone that can be used to complete study procedures

Exclusion Criteria:
Participants will be excluded for any FDA contraindications for NRT use if they:
  1. are pregnant/breastfeeding

  2. had recent cardiovascular trauma such as myocardial infarction

  3. had a stroke within the past 3 months

Contacts and Locations

Locations

Site City State Country Postal Code
1 Rush University Medical Center Chicago Illinois United States 60612

Sponsors and Collaborators

  • Rush University Medical Center
  • Medical University of South Carolina

Investigators

  • Principal Investigator: Amanda Mathew, PhD, Rush University Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Rush University Medical Center
ClinicalTrials.gov Identifier:
NCT05513872
Other Study ID Numbers:
  • 20121702
First Posted:
Aug 24, 2022
Last Update Posted:
Aug 24, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
Yes
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by Rush University Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 24, 2022